MX2019010931A - Metodos, composiciones, y kits para tratar y/o prevenir un efecto secundario asociado con radiacion y/o exposicion a quimioterapia. - Google Patents

Metodos, composiciones, y kits para tratar y/o prevenir un efecto secundario asociado con radiacion y/o exposicion a quimioterapia.

Info

Publication number
MX2019010931A
MX2019010931A MX2019010931A MX2019010931A MX2019010931A MX 2019010931 A MX2019010931 A MX 2019010931A MX 2019010931 A MX2019010931 A MX 2019010931A MX 2019010931 A MX2019010931 A MX 2019010931A MX 2019010931 A MX2019010931 A MX 2019010931A
Authority
MX
Mexico
Prior art keywords
kits
compositions
methods
treating
preventing
Prior art date
Application number
MX2019010931A
Other languages
English (en)
Inventor
Batinic-Haberle Ines
ASHCRAFT Kathleen
Dewhirst Mark
D Crapo James
Original Assignee
Biomimetix Jv Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomimetix Jv Llc filed Critical Biomimetix Jv Llc
Publication of MX2019010931A publication Critical patent/MX2019010931A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Se describen en la presente metodos, composiciones, y kits para tratar y/o prevenir en un sujeto uno o mas efectos secundarios asociados con radiacion y/o exposicion a quimioterapia,incluyendo metodos, composiciones y kits que incluyen un agente activo a una baja dosis; en algunas modalidades, se proporcionan metodos, composiciones, y kits para tratar y/o prevenir daño al tejido en un sujeto, incluyendo metodos, composiciones y kits que incluyen un agente activo a una dosis baja.
MX2019010931A 2017-04-04 2018-04-04 Metodos, composiciones, y kits para tratar y/o prevenir un efecto secundario asociado con radiacion y/o exposicion a quimioterapia. MX2019010931A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762481460P 2017-04-04 2017-04-04
PCT/US2018/026002 WO2018187411A1 (en) 2017-04-04 2018-04-04 Methods, compositions, and kits for treating and/or preventing a side effect associated with radiation and/or chemotherapy exposure

Publications (1)

Publication Number Publication Date
MX2019010931A true MX2019010931A (es) 2020-01-21

Family

ID=63712315

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019010931A MX2019010931A (es) 2017-04-04 2018-04-04 Metodos, composiciones, y kits para tratar y/o prevenir un efecto secundario asociado con radiacion y/o exposicion a quimioterapia.

Country Status (8)

Country Link
US (2) US11285162B2 (es)
EP (1) EP3606614A4 (es)
JP (1) JP7333560B2 (es)
KR (1) KR20190130654A (es)
CN (1) CN110621377A (es)
CA (1) CA3052875A1 (es)
MX (1) MX2019010931A (es)
WO (1) WO2018187411A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3606614A4 (en) * 2017-04-04 2020-10-28 Biomimetix JV LLC PROCEDURES, COMPOSITIONS AND KITS FOR TREATMENT AND / OR PREVENTION OF SIDE EFFECT RELATED TO EXPOSURE TO RADIATION AND / OR CHEMOTHERAPY
CN111011309A (zh) * 2020-03-03 2020-04-17 江西中医药大学 一种化疗药物致大鼠口腔溃疡模型建立方法及其应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6448239B1 (en) 1999-06-03 2002-09-10 Trustees Of Princeton University Peroxynitrite decomposition catalysts and methods of use thereof
ATE439134T1 (de) * 2001-01-19 2009-08-15 Nat Jewish Med & Res Center Medikament zum schutz in der radiotherapie
EP1718201B1 (en) 2004-02-09 2016-09-14 Duke University Substituted porphyrins
CN101235036A (zh) * 2007-02-02 2008-08-06 济南赛文医药技术有限公司 一类卟啉衍生物及其作为小分子抗氧化剂的应用
WO2010080881A1 (en) 2009-01-07 2010-07-15 Duke University Substituted porphyrins
US20160113940A1 (en) 2013-09-03 2016-04-28 Biomimetix J.V., Llc Methods of treating biofilms
WO2015112588A1 (en) * 2014-01-22 2015-07-30 Biomimetix Jv, Llc Methods of treating skin disorders
US10080759B2 (en) * 2014-01-22 2018-09-25 Duke University Methods of treating pruritus
US20190330220A1 (en) * 2016-12-20 2019-10-31 Duke University Methods of making substituted porphyrin pharmaceutical compounds and compositions
EP3606614A4 (en) * 2017-04-04 2020-10-28 Biomimetix JV LLC PROCEDURES, COMPOSITIONS AND KITS FOR TREATMENT AND / OR PREVENTION OF SIDE EFFECT RELATED TO EXPOSURE TO RADIATION AND / OR CHEMOTHERAPY
WO2018237249A1 (en) * 2017-06-22 2018-12-27 Biomimetix Jv, Llc METHODS, COMPOSITIONS AND KITS FOR TREATING AND PREVENTING INFLAMMATORY SKIN DISEASES
CA3076008A1 (en) 2017-09-29 2019-04-04 Duke University Fluoro substituted porphyrin compounds, pharmaceutical compositions comprising the same, and methods of preparing and using the same

Also Published As

Publication number Publication date
EP3606614A1 (en) 2020-02-12
KR20190130654A (ko) 2019-11-22
JP2020515630A (ja) 2020-05-28
WO2018187411A1 (en) 2018-10-11
US20220193090A1 (en) 2022-06-23
JP7333560B2 (ja) 2023-08-25
CA3052875A1 (en) 2018-10-11
EP3606614A4 (en) 2020-10-28
US11285162B2 (en) 2022-03-29
US20210106594A1 (en) 2021-04-15
CN110621377A (zh) 2019-12-27

Similar Documents

Publication Publication Date Title
PH12020551923A1 (en) Methods and compositions for treating cancer
PH12021500004A1 (en) Pd-1/pd-l1 inhibitors
PH12020551244A1 (en) Pd-1/pd-l1 inhibitors
MX2018002723A (es) Macrociclicos peptidomimeticos y usos de los mismos.
CL2017000080A1 (es) Métodos para tratar el cáncer con inhibidores de tigit y agentes contra el cáncer
PH12020550936A1 (en) Combination drug including tlr7 agonist
MX2022001075A (es) Compuestos para usarse en el tratamiento de cancer de mama que expresa el receptor de androgenos (ar+).
EA201591674A1 (ru) Противораковые вакцины и способы лечения с их применением
MX2018008190A (es) Sistemas y metodos para la administracion transdermica a largo plazo.
MX2019008701A (es) Terapia de combinacion que involucra compuestos macrociclicos de diarilo.
MX2015013177A (es) Combinacion de tratamientod de cancer usando microarns e inhibidores de egfr-tki.
MX2019009753A (es) Composicion y metodos para prevenir lesion por radiacion y promover la regeneracion de tejidos.
MX2020000467A (es) Compuestos retinoides y rexinoides inmunomoduladores en combinacion con inmunomoduladores para inmunoterapia contra cancer.
UY35803A (es) Recubrimiento de alginato para tratamiento de esquejes
MX2023000549A (es) Combinaciones para el tratamiento de neoplasias usando localizacion de celulas quiescentes e inhibidores de egfr.
CL2017001964A1 (es) Encapsulado de agentes activos de alta potencia.
MX2020012163A (es) Composiciones de proteccion solar con resistencia al agua mejorada de agentes activos de proteccion solar de rayos ultravioleta (uva).
WO2019157495A3 (en) Methods for preventing and/or treating bone loss conditions by modulating irisin
MX2019015676A (es) Uso de isovaleril espiramicina i, ii y/o iii en la fabricación de medicamentos para el tratamiento y/o la prevención de tumores, y el medicamento.
WO2018208954A3 (en) Peptidomimetic macrocycles and uses thereof
WO2016127123A3 (en) Compounds and methods for preventing or treating sensory hair cell death
WO2017019721A3 (en) Combinations of ezh2 inhibitors with further agents for use in the treatment of cancer
WO2018009507A8 (en) COMBINATION OF A TIM -4 ANTAGONIST AND METHODS OF USE
MX2019010931A (es) Metodos, composiciones, y kits para tratar y/o prevenir un efecto secundario asociado con radiacion y/o exposicion a quimioterapia.
BR112018014723A2 (pt) fantasmas bacterianos para o tratamento de câncer